Management of aldosteronism.
D000236:Adenoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D000310:Adrenal Gland Neoplasms / Q000628:therapy*; D000311:Adrenal Glands / Q000187:drug effects / Q000601:surgery; D000616:Aminoglutethimide / Q000627:therapeutic use; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone / Q000627:therapeutic use*
D000451:Mineralocorticoid Receptor Antagonists; D000616:Aminoglutethimide; D013148:Spironolactone